Advisor Group’s VanEck Pharmaceutical ETF PPH Stock Holding History

Advisor Group’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$50K	Hold	777	–	–	﹤0.01%	3417
2019 Q3	$44K	Buy	777 +277	+55%	+$15.9K	﹤0.01%	3485
2019 Q2	$29K	Sell	500 -200	-29%	-$11.6K	﹤0.01%	3728
2019 Q1	$43K	Sell	700 -18	-3%	-$1.06K	﹤0.01%	3497
2018 Q4	$39K	Sell	718 -335	-32%	-$20.3K	﹤0.01%	3365
2018 Q3	$68K	Sell	1,053 -400	-28%	-$24.9K	﹤0.01%	3057
2018 Q2	$86K	Hold	1,453	–	–	﹤0.01%	2646
2018 Q1	$83K	Hold	1,453	–	–	﹤0.01%	2701
2017 Q4	$86K	Buy	1,453 +1,435	+7,972%	+$82.3K	﹤0.01%	2687
2017 Q3	$1K	Sell	18 -25	-58%	-$1.42K	﹤0.01%	4708
2017 Q2	$2K	Hold	43	–	–	﹤0.01%	4525
2017 Q1	$2K	Hold	43	–	–	﹤0.01%	4401
2016 Q4	$2K	Sell	43 -18	-30%	-$962	﹤0.01%	4233
2016 Q3	$3K	Sell	61 -1,067	-95%	-$64K	﹤0.01%	4082
2016 Q2	$65K	Buy	+1,128	New	+$65.7K	﹤0.01%	2225

Other funds holding PPH

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

WWM

Western Wealth Management Golden, Colorado $2.63B AUM 21.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Advisor Group's PPH Position: Q4 2019 in Review

Advisor Group held its VanEck Pharmaceutical ETF (PPH) position steady in Q4 2019 at 777 shares worth $50K. The position accounts for ﹤0.01% of the portfolio, ranked #3417.

Advisor Group first reported a position in PPH in Q2 2016 and has held it in 15 quarters since. The position peaked at $86K in Q2 2018. 49 funds tracked by Wall St. Rank hold PPH as of Q4 2019.

Advisor Group held 777 shares of VanEck Pharmaceutical ETF worth $50K as of Q4 2019.
Advisor Group left its VanEck Pharmaceutical ETF share count unchanged in Q4 2019.
VanEck Pharmaceutical ETF made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3417 holding.
Advisor Group first reported a position in VanEck Pharmaceutical ETF in Q2 2016 and has held it in 15 quarters since.
Advisor Group's VanEck Pharmaceutical ETF position peaked at $86K in Q2 2018.
49 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.